NeoGenomics Completes Clarient Acquisition

Email not displaying correctly?
View it in your browser.
G2 LogoLab and Pathology Insider Logo
 
January 5, 2015

Pathway Genomics Denies Wrongdoing, Settles False Claims Allegations for $4 Million

By Kelly A. Briganti, Editorial Director, G2 Intelligence

As the year came to a close, the Federal Bureau of Investigation and the U.S. Attorney's Office announced December 30, 2015, a $4 million settlement with Pathway Genomics. The San Diego-based laboratory denied wrongdoing but agreed to pay that sum to resolve…

Read more...


NeoGenomics Completes Clarient Acquisition

By Ron Shinkman, Editor, Laboratory Industry Report

Florida-based NeoGenomics has completed its acquisition of the Clarient Diagnostics unit from GE Healthcare. Clarient provides cancer diagnostics to hospitals, physicians, and drug companies…

Read more...


Simple Patient Info Sheet Not Enough to Dissuade Low-Value Screening

By Lori Solomon, Editor, Diagnostic Testing & Emerging Technologies

Simple, brief, information sheets are unlikely to change patients' intentions to participate in low-value screenings, according to a study published online Dec. 28, 2015 in JAMA Internal Medicine. To reduce overused screening services—including prostate cancer and…

Read more...


CDC Year in Review and Future Plans Include Laboratory Safety

By Kelly A. Briganti, Editorial Director, G2 Intelligence

Laboratory safety and diagnosis of infections figure prominently in the Centers for Disease Control and Prevention's (CDC) review of 2015 and its agenda for 2016. The agency's Year in Review highlighted "the most pressing public health challenges of…

Read more...


Follow on Twitter |  Forward to a Friend

For questions concerning delivery of this email, please contact customer service at: (888) 729-2315 | customerservice@plainlanguagemedia.com

Copyright © 2016, All rights reserved.
Plain Language Media LLLP
PO Box 509
New London, CT 06320